These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10907390)

  • 1. Nonalcoholic steatohepatitis.
    Kumar KS; Malet PF
    Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Non-alcoholic steatohepatitis].
    Alvarez-Martínez H; Pérez-Campos E
    Rev Gastroenterol Mex; 2002; 67(2):118-25. PubMed ID: 12214335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases from the spectrum of nonalcoholic steatohepatitis.
    Abdelmalek M; Ludwig J; Lindor KD
    J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease.
    Paredes AH; Torres DM; Harrison SA
    Clin Liver Dis; 2012 May; 16(2):397-419. PubMed ID: 22541706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus, obesity, and hepatic steatosis.
    Youssef W; McCullough AJ
    Semin Gastrointest Dis; 2002 Jan; 13(1):17-30. PubMed ID: 11944630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial.
    Lindor KD; Kowdley KV; Heathcote EJ; Harrison ME; Jorgensen R; Angulo P; Lymp JF; Burgart L; Colin P
    Hepatology; 2004 Mar; 39(3):770-8. PubMed ID: 14999696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic steatohepatitis.
    Das K; Kar P
    J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orlistat in the treatment of NASH: a case series.
    Harrison SA; Ramrakhiani S; Brunt EM; Anbari MA; Cortese C; Bacon BR
    Am J Gastroenterol; 2003 Apr; 98(4):926-30. PubMed ID: 12738478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic steatohepatitis.
    Diehl AM
    Semin Liver Dis; 1999; 19(2):221-9. PubMed ID: 10422202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.
    Ong JP; Elariny H; Collantes R; Younoszai A; Chandhoke V; Reines HD; Goodman Z; Younossi ZM
    Obes Surg; 2005 Mar; 15(3):310-5. PubMed ID: 15826462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study.
    Georgescu EF; Georgescu M
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):39-46. PubMed ID: 17410287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic therapy of non-alcoholic steatohepatitis.
    Ratziu V; Zelber-Sagi S
    Clin Liver Dis; 2009 Nov; 13(4):667-88. PubMed ID: 19818312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis.
    Ozel Coskun BD; Yucesoy M; Gursoy S; Baskol M; Yurci A; Yagbasan A; Doğan S; Baskol G
    Eur J Gastroenterol Hepatol; 2015 Feb; 27(2):142-9. PubMed ID: 25533429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-alcoholic steato-hepatitis].
    Linhart HG
    Praxis (Bern 1994); 2000 May; 89(22):963-6. PubMed ID: 10893995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic steatohepatitis.
    Brunt EM
    Semin Liver Dis; 2004 Feb; 24(1):3-20. PubMed ID: 15085483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V; Berenguer M; Rayón JM; Carrasco D; Berenguer J
    Am J Gastroenterol; 2002 Sep; 97(9):2408-14. PubMed ID: 12358265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver and nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA
    Clin Cornerstone; 2001; 3(6):47-57. PubMed ID: 11501194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.